DYN · Dyne Therapeutics, Inc.
Market Cap
$4.53B
Shares
186.75M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1818794
CUSIP
26818M108
13F (30d)
170 filings
170 filers
Visit website
Investor relations